Home NDC 63868-079-01 Quality Choice Nasal
Product NDC 63868-079
Requested package NDC 63868-079-01
11-digit product format 638680079
Labeler code 63868
Product ID 63868-079_2d424a6b-6241-4d6c-a6a5-490970c551fc
Type HUMAN OTC DRUG
Nonproprietary name Oxymetazoline hydrochloride
Dosage form SPRAY
Route NASAL
Labeler QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)
Application part341
Marketing category OTC MONOGRAPH FINAL
Marketing start 2019-04-17
Marketing end 0000-00-00
Substance OXYMETAZOLINE HYDROCHLORIDE
Active strength 0 g/100mL
Pharmacologic classes Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63868-079-01 Quality Choice Nasal 30 mL in 1 BOTTLE, SPRAY SPRAY 30 3 63868-079-01 Quality Choice Nasal 1 in 1 CARTON SPRAY 1 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63868-079 QUALITY CHOICE NASAL (OXYMETAZOLINE HYDROCHLORIDE) SPRAY [QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)] 3 Legacy NDC, 2 package rows 20220119_d64a379a-5633-417d-b938-b04650204289.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 63868-079-01 63868007901 1 BOTTLE, SPRAY in 1 CARTON (63868-079-01) > 30 mL in 1 BOTTLE, SPRAY 2019-04-17 0000-00-00 No No Current